What is MabThera (Rituximab)?
MabThera is a monoclonal antibody that targets the CD20 protein found on the surface of certain lymphocytes.
By binding to these cells, the treatment helps to:
- Destroy abnormal cells
- Reduce harmful immune cell activity
- Improve disease control in cancer and autoimmune conditions
In simple terms:
It is a targeted therapy that precisely attacks specific immune cells.
Indications
MabThera (Rituximab) is used in:
- Certain types of lymphoma
- Chronic Lymphocytic Leukemia (CLL)
- Rheumatoid arthritis
- Certain autoimmune diseases
Dosage and Administration
- Dose depends on the condition and treatment protocol
- Administered as an intravenous (IV) infusion
- Given under medical supervision in specialized centers
- May be used alone or in combination with other therapies
Common Side Effects
May include:
- Infusion-related reactions such as fever or chills
- Fatigue
- Nausea
- Reduced immunity
- Mild infections
- Skin rash
Careful monitoring is important during treatment.
Monitoring During Treatment
Patients on MabThera (Rituximab) require:
- Complete blood count monitoring
- Infection surveillance
- Assessment of treatment response
- Organ function monitoring when needed
Availability & How to Access Treatment
MabThera (Rituximab) is available through Macrocare’s approved partners.
You can now request and access the medication easily through us.
WhatsApp contact for medication requests:
Click here
MabThera (Rituximab) MabThera (Rituximab) 100 mg is a targeted biologic therapy used for certain lymphomas and autoimmune diseases by targeting CD20-positive cells to improve disease control.
Medical Disclaimer:
This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.
